Researchers to Study Diabetes Self-Management and Behavioral Interventions
More than 25 million Americans have diabetes, yet as many as 60 percent of type 2 diabetes patients do not follow treatment plans prescribed by their health care provider and about 50 percent fail to meet treatment recommendations for control of blood glucose levels. Consistent adherence to oral medications and injectable insulin, both used to keep blood glucose levels in check, is particularly challenging among young patients and ethnic minorities. Consequences are significant: lack of adherence can lead to or exacerbate eye disease, kidney disease and nerve damage.
David Brooks to Keynote December 8 Convocation; Jack Belz, Dr. Susan Horwitz, Harvey Kaylie and William Zabel to be Honored
David Brooks, acclaimed journalist, author and New York Times columnist will be the keynote speaker and receive an honorary doctorate at Yeshiva University’s 89th Annual Hanukkah Convocation and Dinner on Sunday, December 8, at The Waldorf Astoria in New York City.
New York Times columnist David Brooks will keynote YU’s Hanukkah convocation.
In addition to Brooks, YU President Richard M. Joel will confer honorary degrees upon Jack A. Belz of Memphis, TN, chairman and CEO of Belz Enterprises and a Benefactor and Trustee of Yeshiva University; Harvey Kaylie of Great Neck, NY, founder, president and CEO of Mini-Circuits International and a YU Benefactor; and William Zabel of Manhattan, founding partner of Schulte, Roth & Zabel and head of the Individual Client Services Group. President Joel will also present the Presidential Medallion to Dr. Susan B. Horwitz of Larchmont, NY, Rose Falkenstein Professor of Cancer Research and co-chair of molecular pharmacology at Yeshiva University’s Albert Einstein College of Medicine. Read the rest of this entry…
The conference will explore the ways in which Israeli medical institutions utilize Jewish law to form national policy as well as several important ethical and halachic questions that emerge from practicing medicine in Israel. Read the rest of this entry…
Einstein-Montefiore Researchers Secure $16 Million NIH Grant to Study HIV/AIDS in Women
Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have received a $16 million grant from the National Institutes of Health (NIH) to investigate the impact of HIV and AIDS on women. The funds allow Montefiore and Einstein to continue as a scientific and clinical site for the Women’s Interagency HIV Study (WIHS), a multi-center, prospective, observational study of women who are either HIV-positive or at risk for HIV infection. The study is now entering its 21st year. Read the rest of this entry…
Crohn’s Disease and Ulcerative Colitis More Common Among Ashkenazi Jews
Individuals seeking to learn about Crohn’s disease and ulcerative colitis (collectively known as inflammatory bowel disease or IBD) can self-educate at GeneSights, the free online education resource presented by the Program for Jewish Genetic Health of Yeshiva University/Albert Einstein College of Medicine. IBD affects more than 1.4 million Americans and its prevalence is significantly higher in individuals of Ashkenazi Jewish descent as compared to the general population.
GeneSights consists of individual “lessons” with topics selected based on their current relevance to the Jewish community, including specific diseases and medical conditions, genetic technologies and bioethical issues. Read the rest of this entry…
Eleven YU Undergrads Participate in Advanced Biomedical Research Program
Eleven Yeshiva University undergraduates have been selected to participate in the Summer Undergraduate Research Program (SURP), an advanced biomedical research program at YU’s Albert Einstein College of Medicine. Directed by Dr. Victoria Freedman, Einstein’s associate dean for graduate programs in the biomedical sciences, and Dr. Barry Potvin, professor of biology at Yeshiva College and visiting professor in the cell biology department at Einstein, the program has drawn 58 students in total from a variety of colleges and universities to engage in cutting-edge scientific studies.
Stern College’s Nechama Dreyfus is conducting research in the animal imaging lab at Einstein’s Nuclear Medicine and Biophysics Department.
In fields ranging from neuroscience to epidemiology to microbiology, the students receive hands-on research experience in their areas of interest normally reserved for graduate-level work.
“I’m particularly enjoying my placement in Dr. Linda Jelicks’s animal imaging lab within the Nuclear Medicine and Biophysics Department at Einstein because this technology and field are completely new to me,” said Nechama Dreyfus, a biochemistry major at Stern College for Women. Read the rest of this entry…
Graduate Profile: Tamar Weinberger, Albert Einstein College of Medicine
A common spirit runs throughout Yeshiva University: the mandate to matter.
Students of all ages and backgrounds come here to pursue a range of professional and personal dreams, from scientific research and medicine to law, Jewish education or public policy. Our students seek to harness their unique talents and YU education to make a lasting impact on the world around them. This spring, when they graduate from YU, these new alumni will hit the ground running.
In the weeks leading up to Commencement, YU Newswill feature one remarkable graduate from each school, reflecting, in their own words, on their time here, their passions and their dreams for the future.
Meet the Class of 2013.
With the help of YU’s Anne Scheiber Scholarship, Einstein’s Tamar Weinberger is pursuing a career in pediatric medicine.
I chose medicine because I saw it as an opportunity to combine my love for science with my desire to contribute to patient care. I also enjoy the academic challenge medicine presents: being confronted with myriad signs and symptoms, deducing a differential diagnosis and effectively diagnosing and treating a disease is a challenging and rewarding endeavor. Read the rest of this entry…
“I am constantly reminded that people go into the field of psychology because they want to build civilization, they want to explore ideas and they’re wise enough to know that they don’t want to live in an enclosed bubble,” said YU President Richard M. Joel in his opening remarks to students. “They want to break down silos, bring their disciplines to play with other disciplines and inspire young people to explore their dreams and make those dreams come true.”
Four-Year $720,000 Grant will Enable Stern College’s Marina Holz to Investigate Breast Cancer Cell Growth
The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded Dr. Marina Holz, assistant professor of biology at Yeshiva University’s Stern College for Women, a $720,000 Research Scholar Grant. The four-year grant will be used to continue her work researching how the mTOR pathway affects the growth of estrogen-receptor positive breast cancer.